APA (7th ed.) Citation

Griesel, R., Hill, A., Meintjes, G., & Maartens, G. (2021). Standard versus double dose dolutegravir in patients with HIV-associated tuberculosis: A phase 2 non-comparative randomised controlled (RADIANT-TB) trial [version 1; peer review: 2 approved]. Wellcome.

Chicago Style (17th ed.) Citation

Griesel, Rulan, Andrew Hill, Graeme Meintjes, and Gary Maartens. Standard Versus Double Dose Dolutegravir in Patients with HIV-associated Tuberculosis: A Phase 2 Non-comparative Randomised Controlled (RADIANT-TB) Trial [version 1; Peer Review: 2 Approved]. Wellcome, 2021.

MLA (8th ed.) Citation

Griesel, Rulan, et al. Standard Versus Double Dose Dolutegravir in Patients with HIV-associated Tuberculosis: A Phase 2 Non-comparative Randomised Controlled (RADIANT-TB) Trial [version 1; Peer Review: 2 Approved]. Wellcome, 2021.